Press release
Geron Corporation (NASDAQ: GERN) Investor Alert: Deadline in Lawsuit on May 12, 2025
A Deadline is coming up on May 12, 2025 in the lawsuit for certain investors in Geron Corporation (NASDAQ: GERN).
Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and there are strict and short deadlines running. Deadline: May 12, 2025. Geron Corporation (NASDAQ: GERN) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Geron Corporation (NASDAQ: GERN) common shares between June 7, 2024 and February 25, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 7, 2024 and February 25, 2025, the defendants provided investors with material information concerning defendants' expectations for the launch and growth potential of Rytelo (imetelstat), and that the defendants' statements included, among other things, confidence in Geron's ability to capitalize on the purportedly significant unmet need for the drug and to execute on its commercial plan to target first-line ESA ineligible patients, while continually minimizing the risks associated with the burden of the weekly monitoring requirement for Rytelo and the impacts of seasonality and existing competition on the drug's sales.
Those who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geron Corporation (NASDAQ: GERN) Investor Alert: Deadline in Lawsuit on May 12, 2025 here
News-ID: 4000054 • Views: …
More Releases from Shareholders Foundation, Inc.
Long-Term Investors in shares of Edison International (NYSE: EIX) should contact …
An investigation was announced for current long-term investors in shares of Edison International (NYSE: EIX) concerning potential breaches of fiduciary duties by certain directors of Edison International.
Investors who are current long term investors in Edison International (NYSE: EIX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: EIX…
Long-Term Investors in shares of Merck & Co., Inc. (NYSE: MRK) should contact th …
An investigation was announced for current long-term investors in shares of Merck & Co., Inc. (NYSE: MRK) concerning potential breaches of fiduciary duties by certain directors of Merck & Co., Inc.
Investors who are current long term investors in Merck & Co., Inc. (NYSE: MRK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current…
Investigation announced for Long-Term Investors in shares of Venture Global, Inc …
An investigation was announced for current long-term investors in shares of Venture Global, Inc. (NYSE: VG) concerning potential breaches of fiduciary duties by certain directors of Venture Global, Inc.
Investors who are current long term investors in Venture Global, Inc. (NYSE: VG) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Investigation announced for Long-Term Investors in Monolithic Power Systems, Inc …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Monolithic Power Systems, Inc.
Investors who are current long term investors in Monolithic Power Systems, Inc. (NASDAQ: MPWR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MPWR stocks follows a lawsuit filed against Monolithic…
More Releases for Geron
Stem Cell Umbilical Cord Blood Market to Show Incredible Growth by 2028 | Geron …
This comprehensive Stem Cell Umbilical Cord Blood market analysis sheds insight on the producers' position, which aids in keeping one's business on the go. The essential factors such as end-client market data, channel characteristics, and central members are among the main components to remember for this market study. It provides excellent market assessment and understanding, allowing central members to stay updated and maintain their position in a competitive market. The…
Embryonic Stem Cell Market to see Huge Growth by 2025 | BioTime, Caladrius Biosc …
Latest released the research study on Global Embryonic Stem Cell Market, offers a detailed overview of the factors influencing the global business scope. Embryonic Stem Cell Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Embryonic Stem Cell Market. The study covers emerging…
Stem Cells Industry Market has huge growth in industry 2020 : ViaCyte, Inc. , St …
Stem cell therapies possess significant potential in the treatment of various diseases and injuries. With several public and private organizations playing an active role in funding and encouraging stem cell-based research programs, the global stem cell therapy market is expected to grow at a significant pace during next decade. The stem cell therapy market comprises a range of stem cell-based products which are utilized for the treatment of various diseases…
Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GE …
An investigation was announced for current long-term investors in shares of Geron Corporation (NASDAQ: GERN) concerning potential breaches of fiduciary duties by certain directors and officers of Geron Corporation.
Investors who are current long term investors in Geron Corporation (NASDAQ: GERN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Deadline in Lawsuit for Investors in shares of Geron Corporation (NASDAQ: GERN) …
The Shareholders Foundation announced that a deadline is coming up on March 23, 2020 in the lawsuit filed for certain investors of Geron Corporation (NASDAQ: GERN) over alleged securities laws violations by Geron Corporation.
Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and there are strict and short deadlines running. Deadline: March 23, 2020. NASDAQ: GERN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors in shares of Geron Corporation (NASDAQ: GERN)
An investor, who purchased shares of Geron Corporation (NASDAQ: GERN), filed a lawsuit over alleged violations of Federal Securities Laws by Geron Corporation.
Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and for certain investors are short and strict deadlines running. Deadline: March 23, 2020. NASDAQ: GERN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Geron Corporation was developing imetelstat in partnership…
